Optical Genome Mapping Market To Reach $536.4 Million By 2030

Optical Genome Mapping Market Growth & Trends

The global optical genome mapping market size is estimated to reach USD 536.4 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 26.76% from 2024 to 2030. This can be attributed to developments in studying efficient treatments for a variety of chronic diseases. The ability of optical genome mapping (OGM) to complement other genomic sequencing technologies, such as next-generation sequencing (NGS), has created synergies in genomics research.

Researchers can integrate optical mapping data with NGS data to obtain a more comprehensive view of the genome, which is particularly valuable in clinical diagnostics and cancer research. In August 2023, Bionano Genomics participated in the Cancer Genomics Consortium (CGC) 2023 annual meeting with a wide range of sessions covering the utility of OGM for hematological malignancy and solid tumor cancer research, including poster presentations and scientific platform from Bionano Genomics, which also featured a panel discussion of esteemed researchers from across the cancer genomics field.

Technological advancements have played a significant role in the growth of the OGM industry. Over the years, there have been substantial improvements in the underlying technologies used in optical mapping. High-resolution imaging techniques, such as fluorescence microscopy, have become more sophisticated, enabling researchers to visualize and analyze individual DNA molecules with unprecedented precision. Advancements in DNA labeling methods and data analysis algorithms have enhanced the accuracy and efficiency of OGM, making it a reliable and robust tool for genomic research. In June 2023, Bionano Genomics introduced the Stratys system for high throughput OGM via software for evaluating genomic data for hematologic malignancies.

Moreover, the accessibility of optical mapping technology has also improved, making it more widely available to researchers and institutions. Several companies have developed commercial optical mapping platforms, offering turnkey solutions for genomics research. This commercialization has not only made optical mapping more accessible but has also accelerated its adoption across different sectors.

 Request a free sample copy or view report summary: Optical Genome Mapping Market Report

Optical Genome Mapping Market Report Highlights

• Based on product, the market is segmented into instruments, consumables and reagents, software, services, and others. The services segment dominated the market with a revenue share of 64.74% in 2023. This is attributed to the technological advancements in instruments and the increasing number of service providers. The consumables and reagents segment is expected to grow at a lucrative CAGR over the forecast period

• Based on application, the structural variant detection segment dominated the market in 2023. In contrast, the genome assembly segment is anticipated to exhibit the second fastest CAGR over the forecast period owing to the expanding research on gene expressions, genomic diversity, and complex data sequencing

• Based on end-users, the academic research institutes segment dominated the market in 2023 with a revenue share of 59.87%. On the other hand, the hospitals and clinical laboratories segment is expected to grow at a lucrative CAGR of 30.48% owing to the increasing investment in new drug targets and therapeutic approaches

• Based on region, North America dominated the market in 2023 with the largest revenue share of 45.07%, owing to the growing investments and funding in the biotechnology sector

Optical Genome Mapping Market Segmentation

Grand View Research has segmented the global optical genome mapping market based on product & service, technique, application, end-use, and region:

Optical Genome Mapping Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• Consumables & Reagents

• Software

• Services

Optical Genome Mapping Technique Outlook (Revenue, USD Million, 2018 - 2030)

• Structural Variant Detection

• Genome Assembly

• Microbial Strain Typing

• Others

Optical Genome Mapping Application Outlook (Revenue, USD Million, 2018 - 2030)

• Research

• Diagnostics

Optical Genome Mapping End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology & Pharmaceutical Companies

• Hospitals & Clinical Laboratories

• Academic Research Institutes

Optical Genome Mapping Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • South Korea

  • Singapore

  • Australia

  • India

• Latin America

  • Brazil

• Middle East & Africa

  • South Africa

List Of Key Players in the Optical Genome Mapping Market

• Bionano Genomics

• Nucleome Informatics Private Limited

• Praxis Genomics, LLC,

• SourceBio International Limited (Source BioScience)

• MedGenome

• INRAE (French Plant Genomic Resources Center (CNRGV))

• PerkinElmer (PerkinElmer Genomics)

• Genohub Inc.

• Hofkens Lab

• Cerba